- |||||||||| galantamine extended release / Generic mfg.
Enrollment closed, Trial primary completion date: Effect of Galantamine on Inflammation and Cognition (clinicaltrials.gov) - Nov 4, 2021
P2, N=114, Active, not recruiting,
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2022 --> May 2022
- |||||||||| galantamine extended release / Generic mfg.
Enrollment open, Enrollment change: Effect of Galantamine on Inflammation and Cognition (clinicaltrials.gov) - Jul 16, 2020
P2, N=150, Recruiting,
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2022 --> May 2022 Active, not recruiting --> Recruiting | N=85 --> 150
- |||||||||| galantamine extended release / Generic mfg.
Enrollment closed, Enrollment change: Effect of Galantamine on Inflammation and Cognition (clinicaltrials.gov) - Mar 24, 2020
P2, N=85, Active, not recruiting,
Active, not recruiting --> Recruiting | N=85 --> 150 Recruiting --> Active, not recruiting | N=150 --> 85
- |||||||||| galantamine extended release / Generic mfg.
Trial completion: Galantamine and CBT4CBT Pilot to Prevent Relapse. (clinicaltrials.gov) - Dec 3, 2019
P1, N=6, Completed,
Recruiting --> Active, not recruiting | N=150 --> 85 Active, not recruiting --> Completed
- |||||||||| donepezil / Generic mfg.
Quintuple Hypotheses Targeted in Schizophrenia: Fight Fire With Fire (Regency S-V) - Apr 3, 2019 - Abstract #SIRS2019SIRS_215;
The galantamine-memantine combination was significantly better for cognition than the 1 donepezil-memantine combination in patients with Alzheimer’s disease...Participants received galantamine ER 24 mg and memantine XR 21 mg for four weeks...This combination targets the quintuple hypotheses (dopamine, nicotinic-cholinergic, glutamatergic/NMDA, GABA, and KYNA) concurrently and has the potential to treat positive, cognitive, and primary negative symptoms. The galantamine-memantine combination has the potential to become the first antischizophrenia treatment.
- |||||||||| galantamine extended release / Generic mfg.
Enrollment closed, Enrollment change: Galantamine and CBT4CBT Pilot to Prevent Relapse. (clinicaltrials.gov) - Jan 30, 2019
P1, N=6, Active, not recruiting,
The galantamine-memantine combination has the potential to become the first antischizophrenia treatment. Recruiting --> Active, not recruiting | N=30 --> 6
- |||||||||| galantamine extended release / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: Effect of Galantamine on Short-term Abstinence (clinicaltrials.gov) - Apr 6, 2018
P2, N=98, Completed,
Recruiting --> Active, not recruiting | N=30 --> 6 Recruiting --> Completed | Trial completion date: Mar 2018 --> Nov 2017 | Trial primary completion date: Feb 2018 --> Nov 2017
- |||||||||| galantamine extended release / Generic mfg.
Enrollment change: A Study to Help People Quit Smoking. (clinicaltrials.gov) - Sep 25, 2017
P=N/A, N=60, Completed,
Recruiting --> Completed | Trial completion date: Mar 2018 --> Nov 2017 | Trial primary completion date: Feb 2018 --> Nov 2017 N=35 --> 60
- |||||||||| memantine ER / Generic mfg., galantamine extended release / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia (clinicaltrials.gov) - Oct 12, 2016
P2, N=3, Terminated,
Active, not recruiting --> Completed N=10 --> 3 | Recruiting --> Terminated | Trial primary completion date: Sep 2017 --> Jul 2016; Funding no longer available and PI no longer working at the institution
- |||||||||| galantamine extended release / Generic mfg.
Trial primary completion date: Cognitive Enhancement as a Target for Cocaine Pharmacotherapy (clinicaltrials.gov) - Aug 8, 2016
P=N/A, N=95, Completed,
N=10 --> 3 | Recruiting --> Terminated | Trial primary completion date: Sep 2017 --> Jul 2016; Funding no longer available and PI no longer working at the institution Trial primary completion date: Dec 2015 --> Jun 2016
- |||||||||| galantamine extended release / Generic mfg.
Trial completion, Enrollment change: A Study to Help People Quit Smoking. (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=35, Completed,
Recruiting --> Completed Recruiting --> Completed | N=72 --> 35
- |||||||||| galantamine extended release / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Cognitive Enhancement as a Target for Cocaine Pharmacotherapy (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=95, Completed,
Recruiting --> Completed | N=72 --> 35 Recruiting --> Completed | N=120 --> 95 | Trial primary completion date: Sep 2016 --> Dec 2015
- |||||||||| memantine ER / Generic mfg., galantamine extended release / Generic mfg.
Trial primary completion date: Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia (clinicaltrials.gov) - Sep 28, 2015
P2, N=10, Recruiting,
Recruiting --> Completed | N=120 --> 95 | Trial primary completion date: Sep 2016 --> Dec 2015 Trial primary completion date: Sep 2015 --> Sep 2017
- |||||||||| galantamine extended release / Generic mfg.
Trial primary completion date: Effect of Galantamine on Short-term Abstinence (clinicaltrials.gov) - Sep 25, 2015
P2, N=80, Recruiting,
Trial primary completion date: Sep 2015 --> Sep 2017 Trial primary completion date: Jul 2015 --> Feb 2018
- |||||||||| galantamine extended release / Generic mfg.
Phase classification, Enrollment change, Trial primary completion date: Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse (clinicaltrials.gov) - Oct 10, 2014
P2, N=100, Active, not recruiting,
Active, not recruiting --> Completed Phase classification: P1 --> P2 | N=160 --> 100 | Trial primary completion date: Jun 2014 --> Jan 2015
- |||||||||| galantamine extended release / Generic mfg.
Trial completion: Effect of Galantamine on Smoking Abstinence (clinicaltrials.gov) - Jul 2, 2014
P2, N=13, Completed,
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- |||||||||| galantamine extended release / Generic mfg.
Trial initiation date: A Study to Help People Quit Smoking. (clinicaltrials.gov) - Dec 11, 2013
P=N/A, N=72, Recruiting,
Recruiting --> Active, not recruiting Initiation date: Jul 2013 --> Dec 2013
- |||||||||| galantamine extended release / Generic mfg.
Enrollment open: A Study to Help People Quit Smoking. (clinicaltrials.gov) - Dec 11, 2013
P=N/A, N=72, Recruiting,
Initiation date: Jul 2013 --> Dec 2013 Not yet recruiting --> Recruiting
- |||||||||| galantamine extended release / Generic mfg.
Enrollment closed: Effect of Galantamine on Smoking Abstinence (clinicaltrials.gov) - Sep 17, 2012
P2, N=16, Active, not recruiting,
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
|
